Uncovering barriers to early diagnosis of Alzheimer's disease: a European perspective

Documenti analoghi

• The plasma p‐tau217/BD‐tau ratio improves biomarker short‐term variability in memory clinic patients
  di: Frederikke Kragh Clemmensen, et al.
  Pubblicazione: (2025)
• Application of the revised criteria for diagnosis and staging of Alzheimer's disease: Drug development and clinical practice
  di: Clifford R. Jack, et al.
  Pubblicazione: (2024)
• Why testing and diagnosis for Alzheimer's disease are mission critical
  di: Brent W. Beasley
  Pubblicazione: (2025)
• Donanemab immunogenicity in participants with early symptomatic Alzheimer's disease
  di: Garrett R. Mullins, et al.
  Pubblicazione: (2025)
• System readiness and the patient care pathway for Alzheimer's disease diagnosis and treatment
  di: B. Joy Snider, et al.
  Pubblicazione: (2025)